Form 4: Orthofix Director Shweta Maniar Reports Acquisition of Deferred Stock Units

Director Shweta Maniar reports acquiring 15,152 deferred stock units in Orthofix Medical Inc.

Summary

• On June 18, 2024, Shweta Maniar, a director of Orthofix Medical Inc., acquired 15,152 deferred stock units at a price of $12.87.
• Following the transaction, Maniar beneficially owns 35,232 shares, including 29,506 deferred stock units.
• The deferred stock units vest in full on the first anniversary of the grant date, contingent upon continued service.
• Vested units will settle and convert into common stock within 45 days of termination of service.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't convey any particularly positive or negative sentiment, simply reporting a transaction.

Future Outlook

The deferred stock units will vest on the first anniversary of the grant date, contingent upon continued service, and will be settled within 45 days of termination of service.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in the medical device industry. It provides transparency to investors regarding the holdings of key personnel.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• The vesting of deferred stock units incentivizes the director to remain with the company.

Key Dates